| |
|
|
|
Clearside Biomedi  
|
|
3.3 -0.31 (-0.09%) |
01-27 16:00 |
|
Open: |
3.52 |
Pre close: |
3.61 |
Target:
|
5.05
|
|
High: |
3.6399 |
Low: |
3.25 |
Resistance:
|
4.32
5.05
|
|
Volume: |
642,161 |
Market Cap: |
189M |
Support:
|
2.84
1.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.62
 |
MACD |
MACD(12,26):
|
0.34 |
|
MA(20): |
3.52  |
Signal(12,26,9): |
0.43 |
|
MA(100): |
2.04 |
Stochastic Oscillator |
%K(14,3):
|
39.71 |
|
MA(250): |
2.03 |
%D(3): |
54.74 |
|
Average Volume(K) |
3-Month: |
78309
|
52-Week |
High:
|
4.32 |
|
10-Days: |
103736 |
Low: |
1.10 |
|
RSI |
RSI(14):
|
51.48 |
Change(%): |
-7.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.316 |
Return on Equity (ttm) |
-158.7 |
Shares Out. (M) |
48.35 |
|
EPS Est. Current Year |
-2.100 |
Return on Assets (ttm) |
-40.0 |
Shares Float (M) |
33.04 |
|
EPS Est. Next Year |
-2.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.30 |
|
EPS Est. Next Quarter |
-0.590 |
Qtrly Rev. Growth |
2334.0 |
% Held by Institutions |
41.37 |
|
Forward EPS |
-0.810 |
Gross Profit (p.s.) |
0.045 |
Shares Short (K) |
1000 |
|
Book Value (p.s.) |
0.170 |
EBITDA (p.s.) |
-0.282 |
P/E |
-10.51 |
|
Sales Per Share |
0.203 |
Qtrly Earnings Growth |
0.00 |
P/BV |
19.53 |
|
Profit Margin |
-144.47 |
Operating Cash Flow
(M) |
-7.00 |
P/S |
16.35 |
|
Operating Margin |
-140.85 |
Levered Free Cash Flow
(M) |
-1.71 |
P/CF |
-22.93 |
|
|
|
|
|
|
